Resmed (RMD) Short term Debt (2010 - 2026)

Resmed's Short term Debt history runs 17 years deep, the most recent figure standing at $259.9 million for Q1 2026.

• Quarterly Short term Debt rose 2523.95% year-over-year to $259.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $259.9 million (up 2523.95% YoY) and the FY2025 annual result came in at $9.9 million, changed 0.0% from the prior year.
• Short term Debt was $259.9 million for Q1 2026 at Resmed, roughly flat from $259.9 million in the prior quarter.
• Across five years, Short term Debt topped out at $259.9 million in Q1 2026 and bottomed at $9.9 million in Q3 2024.
• A 5-year average of $54.1 million and a median of $9.9 million in 2023 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2022 — Short term Debt fell 17.5% — and 2025, when it jumped 2526.3%.
• Resmed's Short term Debt stood at $9.9 million in 2022, then slipped by 0.02% to $9.9 million in 2023, then increased by 0.08% to $9.9 million in 2024, then soared by 2523.72% to $259.9 million in 2025, then increased by 0.01% to $259.9 million in 2026.
• Business Quant data shows RMD's Short term Debt at $259.9 million in Q1 2026, $259.9 million in Q4 2025, and $259.9 million in Q3 2025.